Human papillomavirus (HPV) knowledge among 1510 women attending the clinic-based cervical cancer screening program in Sweden.

y = years.n = number.All differences between groups are significant at p .05 except following:ap-value .13 between women ≤29 y and women 30–49 y.bp-value .94 between women ≤29 y and women 30–49 y.cp-value .43 between women ≤29 y and women 30–49 y, .12 between women ≤29 y and women 50–60 y, .22 between women 30–49 y and women 50–60 y.dp-value .19 between women ≤29 y and women 30–49 y.ep-value .52 between women ≤29 y and women 30–49 y, .61 between women ≤29 y and women 30–49 y,. 97 between women 30–49 y and women 50–60 y.fp-value .9 between women ≤29 y and women 30–49 y, .46 between women ≤29 y and women 50–60 y, .37 between women 30–49 y and women 50–60 y.gp-value .41 between women ≤29 y and women 30–49 y, .052 between women ≤29 y and women 50–60 y, .12 between women 30–49 y and women 50–60 y.hp-value .36 between women ≤29 y and women 30–49, .061 between women ≤29 y and women 50–60 y.Human papillomavirus (HPV) knowledge among 1510 women attending the clinic-based cervical cancer screening program in Sweden.